LQDA Liquidia Technologies Inc
Company Analysis
Latest News
🟢 Liquidia Technologies is trading 4.48% up today amid broader biotech-sector strength
Liquidia Technologies is trading at $37.98, up 4.48%, as of 9:45 a.m. EST on October 21, 2026, amid biotech-sector strength. - XBI was reported up 2.10%, with...
🟢 Liquidia Technologies is trading 4.59% up today as biotech ETF XBI rose 2.10%
Liquidia Technologies is trading at $35.70, up 4.59%, with biotech-sector strength the clearest available explanation. - Biotech ETF XBI rose 2.10% during the...
🟢 Liquidia Technologies is trading 5.5% up with no new company-specific announcement identified
Liquidia Technologies is trading 5.5% higher at $36.23 on October 19, 2026; no new company-specific announcement explains the move. - The October 13...
🟢 Liquidia Technologies is trading 4.3% up today as settlement preserves YUTREPIA sales for PAH
Liquidia Technologies is trading 4.3% up at $35.40 on October 15, following a settlement allowing uninterrupted YUTREPIA sales for pulmonary arterial...
🟢 Liquidia Technologies is trading 34% up today after settlement secures continued YUTREPIA commercialization
Liquidia Technologies is trading 34.05% up at $35.94 after announcing a global settlement with United Therapeutics on October 13, 2026, resolving six lawsuits...
Liquidia Reaches $380.7M Global Litigation Settlement with United Therapeutics
Liquidia Corporation has entered into a global settlement agreement with United Therapeutics Corporation (UTC) to resolve all ongoing litigation between the...
Liquidia Pays $381 Million to End Its Legal War — But Can a One-Drug Company Sustain a 44% Pop?
Shares of Liquidia surged as much as 44% in pre-market trading on October 14 after the company announced a sweeping settlement with United Therapeutics that...
🟢 Liquidia Technologies is trading 44% up in pre-market after United Therapeutics settlement resolves six lawsuits
Liquidia Technologies is trading 43.77% up at $38.54 in pre-market on October 14, after its October 13 agreement with United Therapeutics resolved all six...
🟢 Liquidia Technologies is trading 34.17% up in after-hours trading with no clear catalyst identified
Liquidia Technologies is trading at $35.97, up 34.17% after-hours; no clear catalyst has emerged. - The October 13 regular-session close was $26.81. - No...
🔴 Liquidia Technologies is trading 4.55% down today, with biotech weakness a possible factor
Liquidia Technologies is trading 4.55% down at $26.41, with biotech sector weakness a possible contributing factor. - No clear company-specific announcement...
🟢 Liquidia Technologies is trading 11.99% up; catalyst remains unclear
Liquidia Technologies is trading at $30.66, up 11.99%, with the cause of the gain unclear. - No clearly reported overnight catalyst was identified for October...
🟢 Liquidia Technologies is trading 4.3% up in pre-market with no clearly reported overnight catalyst
Liquidia Technologies is trading at $28.56, up 4.29%, in pre-market on October 12, with no clearly reported overnight catalyst identified. - Shares closed at...
🔴 Liquidia Technologies is trading 4.39% down today
Liquidia Technologies is trading 4.39% lower at $26.79, with no new company announcement identified to explain the October 9 decline. - The September 30...
🟢 Liquidia Technologies is trading 5.7% up today
Liquidia Technologies is trading at $28.20, up 5.70%, with no clear company-specific announcement identified to explain the gain. - The company’s...
🟢 Liquidia Technologies is trading 5% up today with no clear company-specific catalyst
Liquidia Technologies is trading 5.13% higher at $27.24 on October 7, 2026, with no clear driver identified. - No fresh company-specific announcement...
🔴 Liquidia Technologies is trading 4.4% down today as investors weigh Delaware patent ruling
Liquidia Technologies is trading 4.4% down at $24.77 as investors continue weighing the September 30 Delaware ruling on Yutrepia patents. - The ruling found...
🔴 Liquidia Technologies is trading 4.1% down today after Delaware ruling finds Yutrepia patent claims infringed
Liquidia Technologies is trading at $26.52, down 4.05%, as the September 30 Delaware ruling weighs. - The court found two United Therapeutics patent claims...
🔴 Liquidia Technologies is trading at 6.5% down today after ruling found Yutrepia infringes patent claims
Liquidia Technologies is trading 6.51% down at $26.77 after a September 30 Delaware ruling found Yutrepia infringes two valid United Therapeutics patent claims...
🔴 Liquidia Technologies is trading 5% down in pre-market after court finds Yutrepia infringes PH-ILD patents
Liquidia Technologies is trading 4.79% lower now at $26.65 after a Delaware federal court ruled that Yutrepia infringes two valid United Therapeutics patent...
Liquidia's Billion-Dollar Drug Just Hit a Legal Wall — Can the Company Survive Without Its Fastest-Growing Market?
Shares of Liquidia crashed as much as 57% on September 30 after a Delaware federal court ruled that its flagship lung drug infringes a valid United...